COCP Cocrystal Pharma, Inc.

Fundamentals / CIK 0001412486 / USD

Cocrystal Pharma, Inc. reported $6.77M in total assets and a net loss of $11.33M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open COCP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$14.38M$7.19M$0-$70.57MFY 2016 Net Income: -$74.87M2016FY 2017 Net Income: -$613K2017FY 2018 Net Income: -$49.05M2018FY 2019 Revenue: $6.56MFY 2019 Net Income: -$48.17M2019FY 2020 Revenue: $2.01MFY 2020 Net Income: -$9.65M2020FY 2021 Net Income: -$14.19M2021FY 2022 Net Income: -$38.84M2022FY 2023 Net Income: -$17.98M2023FY 2024 Net Income: -$17.50M2024FY 2025 Net Income: -$8.83M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- -- -- $2.01M $6.56M -- -- --
Research & Development $5.05M $12.54M $15.17M $12.39M $8.79M $6.03M $4.00M $4.67M $5.82M $101.7M
Total Operating Expenses $9.02M $17.88M $18.56M $38.83M $14.22M $11.60M $54.97M $62.92M $8.26M $105.8M
Operating Income -$9.02M -$17.88M -$18.56M -$38.83M -$14.22M -$9.59M -$48.41M -$62.92M -$8.26M -$105.8M
EBITDA -$8.95M -$17.75M -$18.37M -$38.64M -$14.03M -$9.43M -$48.31M -$62.87M -$8.16M -$105.6M
Interest Income -- -- -- -- -- -- -- -- -$7.0K $126K
Interest Expense -$134K -$537K -$640K $2.0K $4.0K $8.0K $19K $58K -- --
Income Before Tax -$8.83M -$18.63M -- -- -- -$9.65M -$48.17M -$62.63M -$7.49M -$104.3M
Income Tax Expense -- -- -- -- -- -- -- -$13.58M -$6.88M -$29.39M
Net Income -$8.83M -$17.50M -$17.98M -$38.84M -$14.19M -$9.65M -$48.17M -$49.05M -$613K -$74.87M
Basic EPS -$0.78 -$1.72 -$1.87 -$4.77 -$1.92 -$2.04 -$18.08 -$20.96 -$0.36 -$38.08
Diluted EPS -$0.78 -$1.72 -$1.87 -$4.77 -$1.92 -$2.04 -$18.08 -$20.96 -$0.36 -$39.52
Basic Shares Outstanding 11.3M 10.2M 9.7M 8.1M 614.9K 4.6M 2.7K 2.3K 2.0M 2.0M
Diluted Shares Outstanding 11.3M 10.2M 9.7M 8.1M 7.4M 4.6M 2.7K 2.3K 2.0M 2.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $105K $105K $225K -- -- -- -- --
Research & Development $1.98M $2.14M $1.37M $1.62M $954K $1.12M $1.36M $2.04M
Total Operating Expenses $3.59M $3.29M $2.58M $2.48M $2.09M $2.11M $2.34M $3.23M
Operating Income -$3.49M -$3.18M -$2.36M -$2.48M -$2.09M -$2.11M -$2.34M -$3.23M
EBITDA -$3.48M -$3.17M -$2.34M -$2.47M -$2.08M -$2.09M -$2.32M -$3.20M
Interest Expense -$15K -$10K -$22K -$47K -$22K -$28K -$37K -$55K
Income Tax Expense $0 $0 $0 -- -- -- -- --
Net Income -$3.44M -$3.16M -$2.30M -$2.43M -$2.05M -$2.06M -$2.30M -$3.27M
Basic EPS -$0.20 -$0.23 -$0.17 -- -$0.19 -$0.20 -$0.23 --
Diluted EPS -$0.20 -$0.23 -$0.17 -- -$0.19 -$0.20 -$0.23 --
Basic Shares Outstanding 17.4M 13.8M 13.8M -- 11.0M 10.2M 10.2M --
Diluted Shares Outstanding 17.4M 13.8M 13.8M -- 11.0M 10.2M 10.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $7.03M $9.86M $26.35M $37.14M $58.70M $33.01M $7.42M $2.72M $748K $3.60M
Cash & Short-Term Investments $7.03M $9.86M $26.35M $37.14M $58.70M $33.01M $7.42M $2.72M $748K $3.60M
Accounts Receivable, Net -- -- -- -- -- $556K $644K -- $1.0K $21K
Total Current Assets $8.13M $11.58M $29.09M $40.18M $59.32M $34.02M $8.28M $2.94M $2.18M $5.47M
Property, Plant & Equipment, Net $93K $153K $271K $342K $453K $591K $431K $384K $119K $280K
Goodwill -- -- -- -- $19.09M $19.09M $19.09M $65.19M $65.19M $65.19M
Total Non-Current Assets $1.58M $1.88M $2.17M $662K $20.07M $20.23M $20.25M $65.62M $119.2M $119.4M
Total Assets $9.71M $13.46M $31.26M $40.84M $79.39M $54.24M $28.53M $68.56M $121.4M $124.9M
Accounts Payable $890K $1.54M $1.22M $614K $578K $657K $1.51M $616K $494K --
Total Current Liabilities $2.21M $2.43M $3.26M $1.22M $1.54M $1.36M $2.29M $1.56M $1.44M $2.04M
Total Non-Current Liabilities $1.17M $1.50M $1.61M $57K $298K $379K $537K $117K $14.59M $20.52M
Total Liabilities $3.38M $3.93M $4.88M $1.27M $1.84M $1.74M $2.82M $1.67M $16.03M $22.56M
Total Debt (incl. Leases) $1.50M $1.81M $1.85M $297K $534K $597K $817K $331K -- --
Common Stock $13K $10K $10K $8.0K $8.0K $71K $36K $30K $24K $24K
Retained Earnings -$342.2M -$333.4M -$315.9M -$297.9M -$259.1M -$244.9M -$235.3M -$187.1M -$138.0M -$137.4M
Total Stockholders' Equity $6.33M $9.52M $26.38M $39.60M $77.55M $52.51M $25.71M $66.89M $105.4M $102.3M
Total Equity $6.33M $9.52M $26.38M $39.60M $77.55M $52.51M $25.71M $66.89M $105.4M $102.3M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $4.87M $2.17M $4.68M $7.03M $7.73M $4.77M $6.92M $9.86M
Cash & Short-Term Investments $4.87M $2.17M $4.68M $7.03M $7.73M $4.77M $6.92M $9.86M
Total Current Assets $5.51M $3.24M $5.94M $8.13M $8.78M $6.76M $8.83M $11.58M
Property, Plant & Equipment, Net $59K $69K $81K $93K $106K $107K $127K $153K
Total Non-Current Assets $1.26M $1.41M $1.49M $1.58M $1.66M $1.74M $1.83M $1.88M
Total Assets $6.77M $4.65M $7.43M $9.71M $10.45M $8.51M $10.66M $13.46M
Accounts Payable $2.30M $1.89M $1.37M $890K $745K $856K $808K $1.54M
Total Current Liabilities $3.20M $2.62M $2.23M $2.21M $1.52M $1.83M $1.93M $2.43M
Total Non-Current Liabilities $896K $989K $1.08M $1.17M $1.26M $1.34M $1.42M $1.50M
Total Liabilities $4.10M $3.60M $3.31M $3.38M $2.78M $3.17M $3.35M $3.93M
Total Debt (incl. Leases) $1.26M $1.34M $1.42M $1.50M $1.58M $1.66M $1.73M $1.81M
Common Stock $19K $13K $13K $13K $13K $10K $10K $10K
Retained Earnings -$351.2M -$347.7M -$344.5M -$342.2M -$339.8M -$337.8M -$335.7M -$333.4M
Total Stockholders' Equity $2.67M $1.04M $4.12M $6.33M $7.67M $5.33M $7.30M $9.52M
Total Equity $2.67M $1.04M $4.12M $6.33M $7.67M $5.33M $7.30M $9.52M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$8.83M -$17.50M -$17.98M -$38.84M -$14.19M -$9.65M -$48.17M -$49.05M -$613K -$74.87M
Depreciation & Amortization $72K $126K $189K $185K $190K $157K $98K $50K $101K $201K
Stock-Based Compensation $270K $643K $801K $855K $724K $662K $351K $562K $614K $548K
Change in Receivables -- -- -- -- $556K $88K -$644K -- $20K $11K
Operating Cash Flow -$8.19M -$16.48M -$14.67M -$21.43M -$12.72M -$9.83M -$1.56M -$8.29M -$6.90M -$14.65M
Capital Expenditure -$12K -$8.0K -$118K -$74K -$52K -$240K -$145K -$28K -$40K -$51K
Free Cash Flow -$8.20M -$16.49M -$14.78M -$21.51M -$12.77M -$10.07M -$1.71M -$8.32M -$6.94M -$14.71M
Investing Cash Flow -$12K -$8.0K -$118K -$74K -$52K -$240K -$145K $1.37M -$40K $3.0K
Common Stock Issued $154K -- $4.00M -- $38.51M $35.78M $6.64M $7.68M $3.00M $9.01M
Financing Cash Flow $5.37M -- $3.99M -$27K $38.47M $35.66M $6.42M $8.89M $4.08M $9.02M
Net Change in Cash -$2.83M -$16.49M -$10.79M -$21.54M $25.70M $25.59M $4.72M $1.98M -$2.86M -$5.64M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$3.44M -$3.16M -$2.30M -$2.43M -$2.05M -$2.06M -$2.30M -$3.27M
Depreciation & Amortization $10K $12K $12K $13K $13K $21K $25K $28K
Stock-Based Compensation $74K $92K $84K $56K $48K $84K $82K $85K
Operating Cash Flow -$2.30M -$2.52M -$2.34M -$1.74M -$1.36M -$2.15M -$2.94M -$3.16M
Capital Expenditure -- -- -- -- -- -- -- $0
Free Cash Flow -- -- -- -- -- -- -- -$3.16M
Investing Cash Flow -- -- -- -- -- -- -- $0
Net Change in Cash $2.70M -$2.52M -$2.34M -$704K $2.96M -$2.15M -$2.94M -$3.16M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -- -- -- -476.0% -737.4% -- -- --
Net Profit Margin -- -- -- -- -- -479.0% -733.8% -- -- --
Return on Equity (ROE) -139.5% -183.8% -68.2% -98.1% -18.3% -18.4% -187.4% -73.3% -0.6% -73.2%
Return on Assets (ROA) -90.9% -130.1% -57.5% -95.1% -17.9% -17.8% -168.8% -71.5% -0.5% -60.0%
Current Ratio 3.68x 4.77x 8.92x 33.04x 38.40x 25.05x 3.62x 1.89x 1.51x 2.68x
Quick Ratio 3.18x 4.06x 8.08x 30.55x 38.00x 24.72x 3.53x 1.75x 0.52x 1.78x
Debt to Equity 0.24x 0.19x 0.07x 0.01x 0.01x 0.01x 0.03x 0.00x -- --
Revenue Growth (YoY) -- -- -- -- -- -69.3% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -423.7% -951.9% -214.5% -139.5% -126.1% -235.5% -217.0% -183.8%
Return on Assets (ROA) -167.3% -213.8% -118.9% -90.9% -92.6% -147.7% -148.7% -130.1%
Current Ratio 1.72x 1.24x 2.66x 3.68x 5.78x 3.69x 4.57x 4.77x
Quick Ratio 1.52x 0.83x 2.10x 3.18x 5.08x 2.60x 3.58x 4.06x
Debt to Equity 0.47x 1.29x 0.35x 0.24x 0.21x 0.31x 0.24x 0.19x
Source: SEC EDGAR CompanyFacts (CIK 0001412486) · from September 30, 2010 Data through September 30, 2026 · synced Nov 21, 2026, 05:04 UTC · Open in terminal